Oxiracetam Mediates Neuroprotection Through the Regulation of Microglia Under Hypoxia-Ischemia Neonatal Brain Injury in Mice

• Published in: Molecular neurobiology 2021-08, Vol.58 (8), p.3918-3937
• Main Authors: Wang, Dan, Wei, Yanbang, Tian, Jingxia, He, Dong, Zhang, Rui, Ji, Xiaoshuai, Huang, Xiaoming, Sun, Jun, Gao, Jiajia, Wang, Zixiao, Pang, Qi, Liu, Qian
• Format: Article
• Language: English
• Subjects: Animals; Animals, Newborn; Autophagy; Biomedical and Life Sciences; Biomedicine; Brain injury; Cell Biology; Cell Survival - drug effects; Cell Survival - physiology; Cells, Cultured; Hypoxia; Hypoxia-Ischemia, Brain - drug therapy; Hypoxia-Ischemia, Brain - metabolism; Inflammation; Ischemia; Male; Mice; Microglia; Microglia - drug effects; Microglia - metabolism; Neonates; Neurobiology; Neurology; Neuroprotection; Neuroprotection - drug effects; Neuroprotection - physiology; Neuroprotective Agents - pharmacology; Neuroprotective Agents - therapeutic use; Neurosciences; Neurotoxicity; Nootropic Agents - pharmacology; Nootropic Agents - therapeutic use; Oxiracetam; Phagocytosis; Phenotypes; Pyrrolidines - pharmacology; Pyrrolidines - therapeutic use; TOR protein; Transmission electron microscopy
• ISSN: 0893-7648; 1559-1182
• DOI: 10.1007/s12035-021-02376-z

In neonatal hypoxic-ischemic brain damage (HIBD), in addition to damage caused by hypoxia and ischemia, over-activation of inflammation leads to further deterioration of the condition, thus greatly shortening the optimal treatment time window. Ischemic penumbra, the edematous area encompassing the infarct core, is characterized by typical activation of microglia and overt inflammation, and prone to incorporate into the infarct core gradually after ischemia onset. If treated in time, the cells located in the penumbra can survive, thereby impeding the expansion of the infarction. We demonstrated for the first time that in the acute phase of HIBD in neonatal mice, treatment of Oxiracetam (ORC) significantly curtailed the size of ischemic penumbra together with drastic reduction of infarction. By staining various cellular markers, we found that the penumbra was defined and concentrated with activated microglia. We also analyzed transmission electron microscopy and Luminex assay results to elucidate the mechanisms involved. We further confirmed that ORC switched polarization of microglia from the inflammatory towards the alternatively activated phenotype, thus promoting microglia from being neurotoxic into neuroprotective. Meanwhile, ORC decreased proliferation of microglia; however, their functions of phagocytosis and autophagy were otherwise enhanced. Last, we clarified that ORC promoted autophagy through the AMPK/mTOR pathway, which further induced the transition of the inflammatory to the alternatively activated phenotype in microglia. The pro-inflammatory factors secretion was inhibited as well, thereby reducing the progression of the infarction. Taken together, it is concluded that Oxiracetam reduced the expansion of ischemic infarction in part via regulating the interplay between microglia activation and autophagy, which would delay the progression of HIBD and effectively prolong the time window for the clinical treatment of HIBD.